173 related articles for article (PubMed ID: 18487013)
21. Osteonectin promotes prostate cancer cell migration and invasion: a possible mechanism for metastasis to bone.
Jacob K; Webber M; Benayahu D; Kleinman HK
Cancer Res; 1999 Sep; 59(17):4453-7. PubMed ID: 10485497
[TBL] [Abstract][Full Text] [Related]
22. Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo.
Achbarou A; Kaiser S; Tremblay G; Ste-Marie LG; Brodt P; Goltzman D; Rabbani SA
Cancer Res; 1994 May; 54(9):2372-7. PubMed ID: 8162583
[TBL] [Abstract][Full Text] [Related]
23. [Inhibitory effect of silencing heparanase expression with antisense oligodeoxynucleotide on invasive capability of human esophageal squamous cancer cell line TE-13].
Zhu H; Wang SJ; Wang SX; Meng XL; Wang YJ
Ai Zheng; 2005 Dec; 24(12):1431-5. PubMed ID: 16351787
[TBL] [Abstract][Full Text] [Related]
24. Heparanase affects adhesive and tumorigenic potential of human glioma cells.
Zetser A; Bashenko Y; Miao HQ; Vlodavsky I; Ilan N
Cancer Res; 2003 Nov; 63(22):7733-41. PubMed ID: 14633698
[TBL] [Abstract][Full Text] [Related]
25. Heparan sulfate proteoglycans and heparanase--partners in osteolytic tumor growth and metastasis.
Sanderson RD; Yang Y; Suva LJ; Kelly T
Matrix Biol; 2004 Oct; 23(6):341-52. PubMed ID: 15533755
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of matriptase by overexpression of bikunin attenuates cell invasion in prostate carcinoma cells.
Tsui KH; Chang PL; Feng TH; Chung LC; Hsu SY; Juang HH
Anticancer Res; 2008; 28(4A):1977-83. PubMed ID: 18649735
[TBL] [Abstract][Full Text] [Related]
27. Canine prostate stimulates osteoblast function using the endothelin receptors.
LeRoy BE; Sellers RS; Rosol TJ
Prostate; 2004 May; 59(2):148-56. PubMed ID: 15042615
[TBL] [Abstract][Full Text] [Related]
28. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells.
Nadir Y; Brenner B; Gingis-Velitski S; Levy-Adam F; Ilan N; Zcharia E; Nadir E; Vlodavsky I
Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145
[TBL] [Abstract][Full Text] [Related]
29. Expression of heparanase in renal cell carcinomas: implications for tumor invasion and prognosis.
Mikami S; Oya M; Shimoda M; Mizuno R; Ishida M; Kosaka T; Mukai M; Nakajima M; Okada Y
Clin Cancer Res; 2008 Oct; 14(19):6055-61. PubMed ID: 18809970
[TBL] [Abstract][Full Text] [Related]
30. In vivo models of prostate cancer metastasis to bone.
Singh AS; Figg WD
J Urol; 2005 Sep; 174(3):820-6. PubMed ID: 16093963
[TBL] [Abstract][Full Text] [Related]
31. FGF-8b induces growth and rich vascularization in an orthotopic PC-3 model of prostate cancer.
Valta MP; Tuomela J; Vuorikoski H; Loponen N; Väänänen RM; Pettersson K; Väänänen HK; Härkönen PL
J Cell Biochem; 2009 Jul; 107(4):769-84. PubMed ID: 19415685
[TBL] [Abstract][Full Text] [Related]
32. [Establishment of bone metastasis model of prostate cancer in nude mice by intratibia injection of human prostate cancer cell line Du145].
Luo Y; Zhang LL; Ning L; He DL; Fan JH; Hou HL
Zhonghua Nan Ke Xue; 2006 Feb; 12(2):133-6. PubMed ID: 16519149
[TBL] [Abstract][Full Text] [Related]
33. [Differential proteomic analysis and function study of human prostate carcinoma cells with different osseous metastatic tendency].
Song DX; Chen AM; Guo FJ; Liao H; Xie BZ; Zhu B; Chen C
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1197-201. PubMed ID: 18844116
[TBL] [Abstract][Full Text] [Related]
34. The effect of a novel botanical agent TBS-101 on invasive prostate cancer in animal models.
Evans S; Dizeyi N; Abrahamsson PA; Persson J
Anticancer Res; 2009 Oct; 29(10):3917-24. PubMed ID: 19846929
[TBL] [Abstract][Full Text] [Related]
35. Human prostate carcinoma cells produce extracellular heparanase.
Kosir MA; Quinn CC; Zukowski KL; Grignon DJ; Ledbetter S
J Surg Res; 1997 Jan; 67(1):98-105. PubMed ID: 9070190
[TBL] [Abstract][Full Text] [Related]
36. Current trials using bone-targeting agents in prostate cancer.
Tu SM; Lin SH
Cancer J; 2008; 14(1):35-9. PubMed ID: 18303481
[TBL] [Abstract][Full Text] [Related]
37. The alpha-receptor for platelet-derived growth factor as a target for antibody-mediated inhibition of skeletal metastases from prostate cancer cells.
Russell MR; Jamieson WL; Dolloff NG; Fatatis A
Oncogene; 2009 Jan; 28(3):412-21. PubMed ID: 18850002
[TBL] [Abstract][Full Text] [Related]
38. A novel model of bone-metastatic prostate cancer in immunocompetent mice.
Power CA; Pwint H; Chan J; Cho J; Yu Y; Walsh W; Russell PJ
Prostate; 2009 Nov; 69(15):1613-23. PubMed ID: 19585491
[TBL] [Abstract][Full Text] [Related]
39. A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone.
Halvorson KG; Kubota K; Sevcik MA; Lindsay TH; Sotillo JE; Ghilardi JR; Rosol TJ; Boustany L; Shelton DL; Mantyh PW
Cancer Res; 2005 Oct; 65(20):9426-35. PubMed ID: 16230406
[TBL] [Abstract][Full Text] [Related]
40. The role of heparanase in gastrointestinal cancer (Review).
Naomoto Y; Takaoka M; Okawa T; Nobuhisa T; Gunduz M; Tanaka N
Oncol Rep; 2005 Jul; 14(1):3-8. PubMed ID: 15944760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]